DocSym
β
Searchsearch
Search
(L85.8) Other specified epidermal thickening
More details coming soon
46 068 in individuals diagnosis other specified epidermal thickening confirmed
321 deaths with diagnosis other specified epidermal thickening
1% mortality rate associated with the disease other specified epidermal thickening
Diagnosis other specified epidermal thickening is diagnosed Men are 3.96% more likely than Women
23 945
Men receive the diagnosis other specified epidermal thickening
321 (1.3 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
22 123
Women receive the diagnosis other specified epidermal thickening
0 (less than 0.1%)Died from this diagnosis.
Risk Group for the Disease other specified epidermal thickening - Men aged 55-59 and Women aged 60-64
In Men diagnosis is most often set at age 0-89
Less common in men the disease occurs at Age 90-95+Less common in women the disease occurs at Age 30-34, 95+
In Women diagnosis is most often set at age 0-29, 35-94
Disease Features other specified epidermal thickening
Absence or low individual and public risk
Other specified epidermal thickening - what does this mean
Other specified epidermal thickening is a disorder where the epidermal layer of the skin thickens abnormally due to an increase in the number of cells, resulting in a hardening of the skin. this can be caused by a variety of conditions, including an allergic reaction, excessive exposure to the sun, or an underlying medical condition.
What happens during the disease - other specified epidermal thickening
Other specified epidermal thickening is a condition in which the epidermal layer of the skin thickens, resulting in a hardening and roughening of the skin. this condition is believed to be caused by an overproduction of keratinocytes, the cells that produce the keratin that makes up the epidermal layer. this overproduction is thought to be the result of genetic or environmental factors, such as exposure to certain chemicals or uv radiation. treatment typically involves the use of topical creams and ointments to reduce inflammation and improve skin texture.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Review patient's medical history
- Physical examination of the affected area
- Skin biopsy
- Blood tests
- Imaging tests such as X-ray, CT scan, or MRI
- Patch test
Treatment and Medical Assistance
Main Goal of the Treatment: To reduce the thickness of the epidermal layer and improve the patient's quality of life.
- Prescribe topical corticosteroids to reduce inflammation and improve symptoms.
- Prescribe oral retinoids to reduce epidermal thickening.
- Prescribe oral antibiotics to reduce bacterial infection.
- Prescribe topical antifungal medications to reduce fungal infection.
- Prescribe topical immunomodulators to reduce inflammation and improve the skin's immune system.
- Prescribe topical calcineurin inhibitors to reduce inflammation and improve symptoms.
- Prescribe oral antihistamines to reduce itching and discomfort.
- Prescribe topical moisturizers to reduce dryness and improve skin hydration.
- Suggest lifestyle changes to reduce stress and improve overall health.
- Suggest phototherapy to reduce inflammation and improve symptoms.
10 Days of Hospitalization Required
753 Hours Required for Outpatient Treatment
Other specified epidermal thickening - Prevention
The best way to prevent other specified epidermal thickening is to avoid activities that can cause skin damage, such as sun exposure, smoking, and frequent hot showers. additionally, it is important to use a moisturizer regularly and to keep the skin clean and dry to reduce the risk of infection.